Welcome to our dedicated page for SOHM news (Ticker: SHMN), a resource for investors and traders seeking the latest updates and insights on SOHM stock.
SOHM, Inc. (SHMN) is a pharmaceutical, nutraceutical, cosmeceutical, and biotech company that focuses on manufacturing and marketing generic drugs across various treatment categories. The company recently announced the filing of a provisional patent application for its ABBIE 'Smart Gene-Editing' platform, designed to tackle off-target gene-editing limitations. SOHM is strategically organized into different business units, including OTC Self-care, Branded Generics, and Contract Development Manufacturing (CDMO), with a particular focus on gene-editing bio-kits through the ABBIE platform.
With its advanced technology and collaborations with leading biotech organizations like Coastar Therapeutics, SOHM is at the forefront of genome editing technologies, aiming to revolutionize the treatment of genetic diseases and develop innovative therapies. The company's commitment to precision medicine and strategic partnerships places it in a unique position to drive growth and innovation in the pharmaceutical and biotech sectors.
FAQ
What is the current stock price of SOHM (SHMN)?
The current stock price of SOHM (SHMN) is $0.0008 as of January 10, 2025.
What is the market cap of SOHM (SHMN)?
The market cap of SOHM (SHMN) is approximately 1.3M.
What are the core business areas of SOHM, Inc.?
SOHM, Inc. operates in pharmaceutical, nutraceutical, cosmeceutical, and biotech sectors, focusing on manufacturing and marketing generic drugs across various treatment categories.
What recent announcement did SOHM make regarding its ABBIE platform?
SOHM recently filed a provisional patent application for its ABBIE 'Smart Gene-Editing' platform, which aims to address off-target gene-editing limitations and enhance precision in genetic engineering.
What strategic collaborations has SOHM engaged in to advance its gene-editing technologies?
SOHM has partnered with leading biotech organizations like Coastar Therapeutics to leverage innovative drug delivery systems and cutting-edge gene-editing technologies, positioning the company at the forefront of genome editing advancements.
How is SOHM contributing to the field of precision medicine?
SOHM's focus on precision medicine, strategic alliances, and commitment to developing safe and targeted gene-editing solutions demonstrate the company's dedication to revolutionizing the treatment of genetic diseases and driving innovation in the biotech sector.
What sets SOHM apart in the pharmaceutical and biotech industry?
SOHM's advanced technology, business unit structure, and collaborations with key industry players position the company as a leader in genome editing technologies, with a strong emphasis on developing novel therapies and advancing scientific research.
How does SOHM plan to achieve growth and innovation in the pharmaceutical market?
SOHM's strategic approach, focus on gene-editing bio-kits, and expansion into emerging healthcare segments demonstrate the company's commitment to driving revenue growth and making a significant impact in the pharmaceutical and biotech sectors.